pillbase.ru

Vimizim

Active substance: elosulfase alfa

recombinant human n-acetylgalactosamine-6-sulfatase

Centralised EU authorisationActive

Marketing holder: BioMarin International Limited

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
  • recombinant human n-acetylgalactosamine-6-sulfatase
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 2
  • Вимизайм
    концентрат для приготовления раствора для инфузий, 1 мг/мл, 5 мл (original in Russian, GRLS)
    ЛП-005202
    БиоМарин Интернэшнл Лимитед
  • Вимизайм®
    концентрат для приготовления раствора для инфузий, 1 мг/мл, 5 мл (original in Russian, GRLS)
    ЛП-№(001669)-(РГ-RU)
    БиоМарин Интернэшнл Лимитед
US 1
  • VIMIZIM
    INJECTION, SOLUTION, CONCENTRATE · ELOSULFASE ALFA 5 mg/5mL
    68135-100
    BioMarin Pharmaceutical Inc.
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-417d-7c65-9783-1192f7bdc8c8,01a120c5-cb01-7e52-83c5-5c36cb35e93f;count=2 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208e-bc29-786b-ab3e-a2afa966d134;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/002779
Registration status
Active
ATC code
A16AB12
Sources
  • product · EMA · EMEA/H/C/002779 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/002779 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/002779 · Verified 2026-10-09